ATE389719T1 - Behandlungsverfahren mit wisp-polypeptiden - Google Patents
Behandlungsverfahren mit wisp-polypeptidenInfo
- Publication number
- ATE389719T1 ATE389719T1 AT01987803T AT01987803T ATE389719T1 AT E389719 T1 ATE389719 T1 AT E389719T1 AT 01987803 T AT01987803 T AT 01987803T AT 01987803 T AT01987803 T AT 01987803T AT E389719 T1 ATE389719 T1 AT E389719T1
- Authority
- AT
- Austria
- Prior art keywords
- administration
- cartilage
- treatment
- injury
- repair
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24122200P | 2000-10-16 | 2000-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE389719T1 true ATE389719T1 (de) | 2008-04-15 |
Family
ID=22909763
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT10000199T ATE544855T1 (de) | 2000-10-16 | 2001-10-12 | Wisp polypeptide, und deren therapeutische anwendungen |
AT08001040T ATE456655T1 (de) | 2000-10-16 | 2001-10-12 | Behandlungsverfahren unter verwendung von wisp- polypeptiden |
AT01987803T ATE389719T1 (de) | 2000-10-16 | 2001-10-12 | Behandlungsverfahren mit wisp-polypeptiden |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT10000199T ATE544855T1 (de) | 2000-10-16 | 2001-10-12 | Wisp polypeptide, und deren therapeutische anwendungen |
AT08001040T ATE456655T1 (de) | 2000-10-16 | 2001-10-12 | Behandlungsverfahren unter verwendung von wisp- polypeptiden |
Country Status (10)
Country | Link |
---|---|
US (2) | US7687460B2 (de) |
EP (3) | EP1927659B1 (de) |
JP (1) | JP4202128B2 (de) |
AT (3) | ATE544855T1 (de) |
AU (2) | AU2437702A (de) |
CA (1) | CA2425145C (de) |
DE (2) | DE60133301T2 (de) |
ES (3) | ES2381935T3 (de) |
IL (3) | IL155279A0 (de) |
WO (1) | WO2002033085A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4202128B2 (ja) * | 2000-10-16 | 2008-12-24 | ジェネンテック・インコーポレーテッド | Wispポリペプチドを用いる治療方法 |
CA2536396A1 (en) * | 2003-09-11 | 2005-03-24 | Genentech, Inc. | Methods of using wisp antagonists |
SE0401069D0 (sv) | 2004-04-26 | 2004-04-26 | Anamar Medical Ab | Use of Compounds for the Treatment of Diseases and Conditions |
WO2007149328A1 (en) * | 2006-06-20 | 2007-12-27 | Genzyme Corporation | Serum-free media and their uses for chondrocyte expansion |
EP2147311A4 (de) * | 2007-04-26 | 2010-08-11 | Genera Istrazivanja D O O | Blut-biomarker für knochenbruch und knorpelverletzung |
WO2009126349A2 (en) * | 2008-01-18 | 2009-10-15 | Burnham Institute For Medical Research | Methods and compositions related to internalizing rgd peptides |
US10370245B2 (en) * | 2009-06-22 | 2019-08-06 | Sanford-Burnham Medical Research Institute | Methods and compositions using peptides and proteins with C-terminal elements |
CA2767826C (en) * | 2009-07-14 | 2015-11-24 | The Scripps Research Institute | Mesenchymal stem cell differentiation using aniopoietin-like-3 |
US20140037659A1 (en) * | 2011-01-31 | 2014-02-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Snx9 as a novel biomarker for chronic inflammation and associated immunosuppresion and a new regulator of t cell receptor expression and function |
EP2812350B1 (de) | 2012-02-11 | 2019-04-03 | F.Hoffmann-La Roche Ag | R-spondin-translokationen und verfahren damit |
US9301971B2 (en) | 2013-03-08 | 2016-04-05 | Novartis Ag | Peptides and compositions for treatment of joint damage |
JO3564B1 (ar) | 2013-03-08 | 2020-07-05 | Novartis Ag | ببتيدات وتركيبات لعلاج ضرر المفاصل |
CN108697812A (zh) * | 2016-01-14 | 2018-10-23 | 脊核细胞有限责任公司 | 用于软骨细胞或软骨类型细胞再生的细胞混合物 |
WO2017207678A1 (en) * | 2016-06-02 | 2017-12-07 | Nestec S.A. | Methods for treating sarcopenia and muscle injury |
TW202027794A (zh) | 2018-10-03 | 2020-08-01 | 瑞士商諾華公司 | 血管生成素樣3多肽之持續遞送 |
KR102167443B1 (ko) * | 2019-03-25 | 2020-10-19 | 주식회사 카티프라임 | 체외 골관절염 모델 및 이를 이용한 골관절염 치료제 스크리닝 방법 |
CN111700881B (zh) * | 2020-07-02 | 2021-05-18 | 四川大学 | Wnt蛋白\ZIF-8纳米复合体、其制备方法及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364839A (en) | 1990-06-18 | 1994-11-15 | Genetics Institute, Inc. | Osteoinductive pharmaceutical formulations |
US5206023A (en) | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5408040A (en) | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
JPH09507750A (ja) | 1993-12-22 | 1997-08-12 | メルク エンド カンパニー インコーポレーテッド | Wnt−x増殖因子をコードするDNA |
US5444047A (en) * | 1994-06-16 | 1995-08-22 | Dipasquale; Gene | Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I |
WO2000053753A2 (en) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
PT990000E (pt) | 1996-11-08 | 2005-11-30 | Human Genome Sciences Inc | Factor 3 de crescimento do tecido conjuntivo |
CA2294564A1 (en) * | 1997-06-19 | 1998-12-23 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a growth factor-like protein |
US20020192209A1 (en) * | 1997-09-17 | 2002-12-19 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
JP2003533164A (ja) * | 1997-10-29 | 2003-11-11 | ジェネンテック・インコーポレーテッド | Wnt−1誘導分泌ポリペプチド:WISP−1,−2及び−3 |
AU4411499A (en) * | 1998-06-05 | 1999-12-20 | Human Genome Sciences, Inc. | Connective tissue growth factor-4 |
KR100342045B1 (ko) * | 1999-04-16 | 2002-06-27 | 김순택 | 2차전지 |
AU6088900A (en) * | 1999-07-23 | 2001-02-13 | Case Western Reserve University | Novel methods and reagents useful in the treatment of osteoarthritis |
US20020063763A1 (en) * | 2000-11-29 | 2002-05-30 | Mantell David Allen | Apparatus and method for removing air bubbles from an ink jet printhead |
GB9930768D0 (en) * | 1999-12-29 | 2000-02-16 | Pfizer Ltd | Composition |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
JP4202128B2 (ja) * | 2000-10-16 | 2008-12-24 | ジェネンテック・インコーポレーテッド | Wispポリペプチドを用いる治療方法 |
-
2001
- 2001-10-12 JP JP2002536453A patent/JP4202128B2/ja not_active Expired - Fee Related
- 2001-10-12 ES ES10000199T patent/ES2381935T3/es not_active Expired - Lifetime
- 2001-10-12 EP EP08001040A patent/EP1927659B1/de not_active Expired - Lifetime
- 2001-10-12 ES ES08001040T patent/ES2338492T3/es not_active Expired - Lifetime
- 2001-10-12 EP EP10000199A patent/EP2180053B1/de not_active Expired - Lifetime
- 2001-10-12 DE DE60133301T patent/DE60133301T2/de not_active Expired - Lifetime
- 2001-10-12 CA CA2425145A patent/CA2425145C/en not_active Expired - Fee Related
- 2001-10-12 AT AT10000199T patent/ATE544855T1/de active
- 2001-10-12 EP EP01987803A patent/EP1326980B1/de not_active Expired - Lifetime
- 2001-10-12 WO PCT/US2001/032142 patent/WO2002033085A2/en active Application Filing
- 2001-10-12 DE DE60141236T patent/DE60141236D1/de not_active Expired - Lifetime
- 2001-10-12 AU AU2437702A patent/AU2437702A/xx active Pending
- 2001-10-12 AU AU2002224377A patent/AU2002224377B2/en not_active Ceased
- 2001-10-12 US US10/399,093 patent/US7687460B2/en not_active Expired - Fee Related
- 2001-10-12 AT AT08001040T patent/ATE456655T1/de active
- 2001-10-12 ES ES01987803T patent/ES2304401T3/es not_active Expired - Lifetime
- 2001-10-12 IL IL15527901A patent/IL155279A0/xx unknown
- 2001-10-12 AT AT01987803T patent/ATE389719T1/de active
-
2003
- 2003-04-08 IL IL155279A patent/IL155279A/en not_active IP Right Cessation
-
2009
- 2009-08-07 US US12/537,888 patent/US8138152B2/en not_active Expired - Fee Related
- 2009-08-19 IL IL200484A patent/IL200484A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60133301T2 (de) | 2009-05-14 |
EP1927659A1 (de) | 2008-06-04 |
EP2180053A2 (de) | 2010-04-28 |
IL155279A (en) | 2011-05-31 |
ATE456655T1 (de) | 2010-02-15 |
US7687460B2 (en) | 2010-03-30 |
ES2304401T3 (es) | 2008-10-16 |
DE60141236D1 (de) | 2010-03-18 |
EP2180053A3 (de) | 2010-11-10 |
EP2180053B1 (de) | 2012-02-08 |
AU2002224377B8 (en) | 2002-04-29 |
AU2002224377B2 (en) | 2007-07-19 |
AU2437702A (en) | 2002-04-29 |
US20050054563A1 (en) | 2005-03-10 |
CA2425145C (en) | 2011-08-30 |
DE60133301D1 (de) | 2008-04-30 |
EP1326980A2 (de) | 2003-07-16 |
IL200484A0 (en) | 2010-04-29 |
US8138152B2 (en) | 2012-03-20 |
IL155279A0 (en) | 2003-11-23 |
ES2338492T3 (es) | 2010-05-07 |
JP4202128B2 (ja) | 2008-12-24 |
EP1326980B1 (de) | 2008-03-19 |
US20100093628A1 (en) | 2010-04-15 |
IL200484A (en) | 2012-05-31 |
EP1927659B1 (de) | 2010-01-27 |
WO2002033085A3 (en) | 2003-04-17 |
ES2381935T3 (es) | 2012-06-01 |
JP2004534720A (ja) | 2004-11-18 |
CA2425145A1 (en) | 2002-04-25 |
WO2002033085A2 (en) | 2002-04-25 |
WO2002033085A9 (en) | 2002-07-25 |
ATE544855T1 (de) | 2012-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL200484A0 (en) | Use of wisp polypeptides wisp for the preparation of medicaments | |
IL151408A0 (en) | Use of insulin for the treatment of cartilagenous disorders | |
ATE265529T1 (de) | Bmp-10 zusammensetzungen | |
DE69729125D1 (de) | Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese | |
DE69835810D1 (de) | Osteogene vorrichtungen und verfahren zu ihrer verwendung zur knochenreparatur | |
DE69433530D1 (de) | Bmp-11 zusammensetzungen | |
ES2182902T3 (es) | Sistema de reparacion de superficies de articulaciones. | |
ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
PT807633E (pt) | Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6) | |
EA200400734A1 (ru) | Способ и композиция для потенциирования действия опиатного анальгетика | |
DE69821793D1 (de) | Neuronale verwendungen des bmp-11 | |
ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
IT1293305B1 (it) | Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi | |
DE69808475T2 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DK0918455T3 (da) | Anvendelse af galanin til reparation af nerveskader | |
DE69941134D1 (de) | Verwendung von R (+)- g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol zur Behandlung von Schlafstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1326980 Country of ref document: EP |